Research outputs
2025
Establishing reference ranges for circulating biomarkers of drug-induced liver injury in healthy human volunteers<SUP>1</SUP>
Jorgensen, A. L., Korver, S., Schofield, A., Howell, L., Clarke, J. I., Walker, L. E., . . . Pirmohamed, M. (2025). Establishing reference ranges for circulating biomarkers of drug-induced liver injury in healthy human volunteers<SUP>1</SUP>. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 91(5), 1361-1369. doi:10.1111/bcp.16371
2023
Advanced statistics identification of participant and treatment predictors associated with severe adverse effects induced by fluoropyrimidine-based chemotherapy.
Korver, S. K., Bowen, J. M., Gibson, R. J., Ball, I. A., Secombe, K. R., Wain, T. J., . . . Coller, J. K. (2023). Advanced statistics identification of participant and treatment predictors associated with severe adverse effects induced by fluoropyrimidine-based chemotherapy.. Cancer chemotherapy and pharmacology, 91(6), 507-521. doi:10.1007/s00280-023-04538-3
2021
The application of cytokeratin-18 as a biomarker for drug-induced liver injury
Korver, S., Bowen, J., Pearson, K., Gonzalez, R. J., French, N., Park, K., . . . Goldring, C. (2021). The application of cytokeratin-18 as a biomarker for drug-induced liver injury. ARCHIVES OF TOXICOLOGY, 95(11), 3435-3448. doi:10.1007/s00204-021-03121-0
2019
Toll-like receptor/interleukin-1 domain innate immune signalling pathway genetic variants are candidate predictors for severe gastrointestinal toxicity risk following 5-fluorouracil-based chemotherapy
Korver, S. K., Gibson, R. J., Bowen, J. M., & Coller, J. K. (2019). Toll-like receptor/interleukin-1 domain innate immune signalling pathway genetic variants are candidate predictors for severe gastrointestinal toxicity risk following 5-fluorouracil-based chemotherapy. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 83(2), 217-236. doi:10.1007/s00280-018-3729-y